Silica Corpora
Description: AI-driven antibody drug design for rapid lead generation, cutting development time from years to days.
Country: Germany
Based in: Berlin
Founded: 2022
Funding Stage: Pre-Seed
Tags: ['AI', 'Health']
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.
